Comparison of Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting and Medical Therapy in Non-ST Elevation Acute Coronary Syndrome Patients With 3-Vessel Disease
Comparison of Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting and Medical Therapy in Non-ST Elevation Acute Coronary Syndrome Patients With 3-Vessel Disease
复制标题
经皮冠状动脉介入治疗、冠状动脉搭桥术与药物治疗非ST段抬高型急性冠状动脉综合征三支血管病变患者的比较
DOI：
10.1253/circj.cj-20-0300
复制
发表时间：
2020-10-01
影响因子：
3.3
通讯作者：
Song, Lei
中科院分区：
文献类型：
--
作者：
Jia, Sida;Zhang, Ce;Song, Lei
背景：本研究的目的是比较接受经皮冠状动脉介入治疗（PCI）、冠状动脉旁路移植术（CABG）或药物治疗（MT）的患有3支血管疾病（3VD）的非ST段抬高急性冠状动脉综合征（NSTEACS）患者的长期预后。方法和结果：总体而言，3,928名患有3VD的NSTE-ACS患者获得了 2004年4月至2011年2月连续入组于阜外医院。患者的中位随访时间为7.5年，根据治疗情况分为PCI组、CABG组或MT组。与接受PCI的患者相比，CABG患者的心肌梗死（MI）、非计划血运重建、主要不良心脑血管事件（MACCE）发生率较低，脑卒中发生率较高（所有P
Background: The aim of this study is to compare the long-term prognosis of non-ST elevation acute coronary syndrome (NSTEACS) patients with 3-vessel disease (3VD) who underwent percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) or medical therapy (MT).Methods and Results: Overall, 3,928 NSTE-ACS patients with 3VD were consecutively enrolled from April 2004 to February 2011 at Fu Wai Hospital. Patients were followed up for a median of 7.5 years, and were divided into PCI, CABG or MT groups according to their treatment. Compared with patients undergoing PCI, CABG patients had lower rates of myocardial infarction (MI), unplanned revascularization, major adverse cardiovascular and cerebrovascular events (MACCE) and a higher rate of stroke (all P